Ehrlichiosis: Difference between revisions
Shanshan Cen (talk | contribs) (→Causes) |
Shanshan Cen (talk | contribs) |
||
Line 50: | Line 50: | ||
---- | ---- | ||
==Risk Factors== | ==Risk Factors== |
Revision as of 17:02, 6 August 2015
Ehrlichiosis | |
ICD-10 | A79.8 |
---|---|
ICD-9 | 082.4 |
DiseasesDB | 31663 |
MedlinePlus | 001381 |
MeSH | D016873 |
Ehrlichiosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Ehrlichiosis On the Web |
American Roentgen Ray Society Images of Ehrlichiosis |
For patient information on this page, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
Synonyms and keywords: Sennetsu fever; human granulocytic ehrlichiosis; Anaplasma phagocytophilum; Ehrlichia phagocytophila; human monocytic ehrlichiosis
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Ehrlichiosis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Future or Investigational Therapies
Case Studies
Risk Factors
Risk factors for ehrlichiosis include:
- Living near an area with a lot of ticks
- Owning a pet that may bring a tick home
- Walking or playing in high grasses
Natural History, Complications and Prognosis
Complications
- Respiratory distress syndrome
- Hepatitis
- Kidney damage
- Lung damage
- Other organ damage
- Seizure
- Candidiasis
- Opportunistic nosocomial infections[1]
- Death
Diagnosis
Symptoms
Other possible symptoms include:
- Diarrhea
- Fine pinhead-sized areas of bleeding in the skin (petechial rash)
- Flat red rash (maculopapular rash)
- General ill feeling (malaise)
A rash appears in fewer than half of cases.
Physical Examination
Vitals
Skin
Head
Laboratory Findings
- Complete blood count (CBC)
- Granulocyte stain
- Fluorescent antibody test
Treatment
- Doxycycline is the drug of choice.
- For people allergic to drugs of the tetracycline class, rifampicin is an alternative.[3]
- Early clinical experience suggested that chloramphenicol may also be effective, however in vitro susceptibility testing revealed resistance.
Antimicrobial regimen
- 1. Human Monocytic Ehrlichiosis or Human Granulocytic Anaplasmosis (adult) [4]
- Preferred regimen: Doxycycline 100 mg PO/IV q12h for 7-14 days
- Note: Patients should be treated for at least 3 days after the fever subsides and until there is evidence of clinical improvement
- Alternative regimen (1): Chloramphenicol 500mg PO qid
- Alternative regimen (2): Rifampin 600 mg PO/IV qd for 7-10 days
- 2. Human Monocytic Ehrlichiosis or Human Granulocytic Anaplasmosis (pediatric)
- 2.1 ≥ 8 years old
- Preferred regimen: Doxycycline 2 mg/kg IV/PO q12h (Maximum, 200 mg/day) for 10 days
- 2.2 < 8 years old without Lyme disease
- Preferred regimen: Doxycycline 2 mg/kg IV/PO q12h (Maximum, 200 mg/day) for 4-5 days (or 3 days after resolution of fever)
- 2.3 co-infected with Lyme disease
- Preferred regimen: Doxycycline, then Amoxicillin 50 mg/kg in 3 divided doses (Maximum, 500 mg/dose) OR Cefuroxime 30 mg/kg in 2 divided doses (Maximum, 500 mg/dose) for 14 days
References
- ↑ Thomas, Rachael J (1 August 2009). "Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and ehrlichiosis". Expert Review of Anti-infective Therapy. 7 (6): 709–722. doi:10.1586/eri.09.44. PMC 2739015. PMID 19681699. Unknown parameter
|month=
ignored (help); Unknown parameter|coauthors=
ignored (help) - ↑ Marty AM, Dumler JS, Imes G, Brusman HP, Smrkovski LL, Frisman DM (1995). "Ehrlichiosis mimicking thrombotic thrombocytopenic purpura. Case report and pathological correlation". Hum. Pathol. 26 (8): 920–5. doi:10.1016/0046-8177(95)90017-9. PMID 7635455. Unknown parameter
|month=
ignored (help) - ↑
- ↑ Bartlett, John (2012). Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases. Burlington, MA: Jones and Bartlett Learning. ISBN 978-1449625580.